NextCure (FRA:2US) Shares Buyback Ratio % : -0.37 (As of Apr. 12, 2025)

View and export this data going back to 2019. Start your Free Trial

What is NextCure Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. NextCure's current shares buyback ratio was -0.37%.

NextCure Shares Buyback Ratio % Historical Data

The historical data trend for NextCure's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCure Shares Buyback Ratio % Chart

NextCure Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-0.25

-0.41

-0.34

-0.46

-0.37

NextCure Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-0.23	-	-0.26	-	-0.11

NextCure Shares Buyback Ratio % Calculation

NextCure's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(27.903	-	28.007)	/	27.903
	=	-0.37%

NextCure's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Sep. 2024 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Sep. 2024 )
	=	(27.976	-	28.007)	/	27.976
	=	-0.11%

NextCure Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of NextCure's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCure Inc (FRA:2US) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

NXTC:USA

Address

9000 Virginia Manor Road, Suite 200, Beltsville, MD, USA, 20705

Website

https://www.nextcure.com

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

NextCure Headlines

No Headlines